ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1552	51	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
692	Surprised at late UK submission date but at least with AA we know approval decis	Redman1234	-	11/12/2024
691	The 7 international regulators by IRP are Australia, Canada, European Commission	Redman1234	-	11/3/2024
690	I was looking to get an idea on UK’s Medicine's and Healthcare Products Regu	Redman1234	4	11/3/2024
689	On June 11 ImmunityBio had its Annual Meeting of Stockholders with Company Updat	Redman1234	9	10/27/2024
688	Yeah, that's the average of them. [graphic][graphic]	erippetoe	-	10/25/2024
687	I just noticed Yahoo finance page has changed the 1 year Target Estimate which w	Redman1234	1	10/25/2024
686	Not suggesting but appears to be active. Got lucky and picked up 5k at $3.50 We	erippetoe	3	10/25/2024
685	are you suggesting that the long awaited "short squeeze" with already	urslor	1	10/25/2024
684	This Biotech Stock Could Rocket 800%, Analyst Says By Elsa Ohlen Follow Updat	End2War	-	10/25/2024
683	Still 51M+ shares short as of last week… Short Interest	erippetoe	1	10/24/2024
682	I believe PSS was born in South Africa.	waitwatchwander	-	10/24/2024
681	Elsa Ohlen It can be hard to astonish analysts, especially those who have been	erippetoe	8	10/24/2024
680	First Patients Dosed in Phase 1 Clinical Study of ImmunityBio's CAR-NK Cell	erippetoe	1	10/24/2024
679	This is a comment on X from Rose Han IBRX ImmunityBio Initiated with a Buy Rat	End2War	1	10/23/2024
678	Maybe OT, but doesn't this concern you? EF Hutton ... livemint.com	waitwatchwander	-	10/23/2024
677	If anyone has the full report please share. Curious how they get to $30, which t	TinfoilHat	4	10/23/2024
676	Saw that. Hopefully a beginning of a trend.	Davidoff	-	10/23/2024
675	FWIW DJ ImmunityBio Initiated at Buy by EF Hutton ImmunityBio Price Target A	bgscolt	3	10/23/2024
674	With todays withdraw of Gilead's drug Trodelvy for bladder cancer would that	bgscolt	1	10/18/2024
673	What happened to your DBGI?	Davidoff	-	10/18/2024
672	That is next level stuff. In the short term, I have no doubt Merck and others w	ghettogoulash	-	10/17/2024
671	Interesting reddit.com	erippetoe	4	10/11/2024
670	It normally takes time to see significant order flow for new drugs, even if ther	End2War	-	10/3/2024
669	The question is, what constitutes substantial revenue in IBRX terms? In my opini	Huggenberg	-	10/2/2024
668	Consistent with what you guys are saying, I just want to mention that Adcock spo	End2War	2	9/30/2024

Go to reply# or date (mm/dd/yy):